Pfizer Partners with 探花合集 for the Manufacture of Advil庐 Liqui-Gels庐 Minis
The innovative product delivers pain relief in a more concentrated fill resulting in a smaller, more convenient capsule. Smaller capsules are easier to swallow for consumers who may have difficulty swallowing, especially for the pediatric and geriatric markets.
Advil is one of the world鈥檚 leading brands of ibuprofen pain relievers and its Liqui-Gels franchise is one of the most successful dose forms in the analgesics market.
鈥溙交ê霞 is proud to collaborate with Pfizer to develop Advil Liqui-Gels Minis and to bring this even more convenient and consumer-friendly dose form to market,鈥 commented Dr. Aris Gennadios, 探花合集鈥檚 President of Softgel Technologies. Under the arrangement, 探花合集鈥檚 St. Petersburg, Florida, facility has already formulated and is manufacturing the new format for Pfizer, with the new product recently launched in the U.S. market.
Media Contacts:
Chris Halling
+44 (0)7580 041073
[email protected]
Richard Kerns
+44 (0) 161 728 5880
[email protected]
About 探花合集
探花合集 is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 90 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 探花合集 employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2016 generated more than $1.85 billion in annual revenue. 探花合集 is headquartered in Somerset, N.J. For more information, visit www.catalent.com